This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

      

You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

652 results

SK bioscience and GSK start Phase 3 trial of adjuvanted COVID-19 vaccine candidate

31-08-2021
Advance to Phase 3 follows positive interim Phase 1/2 immunogenicity and safety data

Second-Generation mRNA COVID-19 Vaccine Candidate, CV2CoV, Demonstrates Improved Immune Response and Protection in Preclinical Study

16-08-2021
Preclinical study provides evidence for strongly improved immune responses with second-generation mRNA backbone

GSK and Alector announce global collaboration in immuno-neurology for two clinical stage first-in-class monoclonal antibodies for neurodegenerative diseases

02-07-2021
GSK and Alector to co-develop progranulin-elevating monoclonal antibodies, AL001 and AL101, for a range of neurodegenerative diseases

Elliott Advisors (UK) letter to GSK

02-07-2021
The Board of GSK notes the letter issued by Elliott Advisors (UK) Limited (“Elliott”) on 1 July

Viiv healthcare and halozyme enter global collaboration and license agreement or enhanze rug delivery technology to enable development of ultra long acting medicines for hiv

22-06-2021
Halozyme’s technology provides more “shots on goal” to create ultra long-acting HIV medicines with dosing intervals of 3 months or longer.

GSK and vir biotechnology announce continuing progress of the comet clinical development programme for sotrovimab

14-06-2021
GSK now has the leading portfolio of antibodies targeting the CD226 axis - a key target for next-generation immuno-oncology therapies

GSK and iteos therapeutics announce development

14-06-2021
GSK now has the leading portfolio of antibodies targeting the CD226 axis - a key target for next-generation immuno-oncology therapies

GSK to showcase scientific advances and progress in oncology at ASCO and EHA

01-06-2021
GSK will showcase innovative approaches to oncology R&D and cutting-edge science at the upcoming ASCO and EHA meetings.

Sanofi and GSK initiate global Phase 3 clinical efficacy study of COVID-19 vaccine candidate

27-05-2021
Pending positive Phase 3 outcomes and regulatory reviews, the vaccine could be approved in Q4 2021

GSK and Vir Biotechnology announce sotrovimab (VIR-7831) receives Emergency Use Authorization from the US FDA

26-05-2021
GSK and Vir Biotechnology announce sotrovimab (VIR-7831) receives Emergency Use Authorization from the US FDA

EMA issues positive scientific opinion on GSK and Vir Biotechnology’s sotrovimab for the early treatment of COVID-19

21-05-2021
Opinion based on the EMA’s CHMP review of available data on sotrovimab (previously VIR-7831) for the early treatment of COVID-19.

Medicago and GSK announce positive interim Phase 2 results for adjuvanted COVID-19 vaccine candidate

18-05-2021
Neutralizing antibody responses were ten times higher than in people recovering from COVID-19.

Sanofi and GSK COVID-19 vaccine candidate demonstrates strong immune responses across all adult age groups in Phase 2 trial

17-05-2021
Adjuvanted recombinant COVID-19 vaccine candidate triggered strong neutralizing antibody responses in all adult age groups.

european-commission-approves-benlysta-for-adult-patients-with-active-lupus-nephritis

05-05-2021
Inspiration Bytes Newsletter for Augmentin

European Commission approves Benlysta for adult patients with active lupus nephritis

05-05-2021
First and only biologic approved for both systemic lupus erythematosus and lupus nephritis

test_page

12-08-2020
test_page

Duration of antibiotic therapy for diabetic foot infections

12-08-2020
Diabetic foot infections (DFIs) are associated with a high rate of recurrence or new episodes, prompting many clinicians to prescribe a longer duration of antibiotic therapy than guidelines recommend. This study assessed the relationships between duration and route of antibiotic therapy and risk of recurrence of DFI.* CA-SSTIs: Community-acquired Skin and Soft-tissue Infections.

Duration of surgical antimicrobial prophylaxis by facility type

12-08-2020
Guidelines recommend discontinuation of surgical antimicrobial prophylaxis within 24 h after skin closure. However, dissemination of recommended practices may vary. This study evaluated how facility complexity impacts adherence to guidelines for the timely discontinuation of antimicrobial prophylaxis after outpatient surgery.

Management of cellulitis – room for improvement

12-08-2020
Cellulitis can be a challenge to manage and is associated with high rates of recurrence. Overuse or inappropriate use of antibiotics is a concern. This review explores issues with its management and approaches to minimise the need for antibiotic therapy. * CA-SSTIs: Community-acquired Skin and Soft-tissue Infections.

Antibiotic guideline adherence vs outcomes

12-08-2020
French guidelines on erysipelas and necrotising fasciitis were published in 2000 and the microbial epidemiology of these infections has not signifi cantly changed since then. This study measured the clinical impact of a guideline-based internal hospital protocol for community-acquired erysipelas and cellulitis in a French tertiary care centre. * CA-SSTIs: Community-acquired Skin and Soft-tissue Infections.

Expert consensus on managing SSTIs in children

12-08-2020
With changing epidemiology of paediatric SSTIs, especially the increase in community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infections, there is a need for an update on management strategies. Hence, an intersociety consensus document has been developed to provide practical recommendations for managing bacterial impetigo, abscess, and cellulitis in children. * CA-SSTIs: Community-acquired Skin and Soft-tissue Infections.

A new SSI risk score for cardiac surgery patients

12-08-2020
The high morbidity and mortality associated with surgical site infection (SSI) in cardiac surgery patients have led to previous attempts to stratify SSI risk using various scoring systems, but their discriminatory abilities are limited. In this study, an analysis of SSI risk factors in cardiac surgery patients was performed and a new SSI risk score developed and assessed.

A preventive bundle to reduce SSIs in gynaecologic oncology

12-08-2020
Surgical site infections (SSIs) are a common and serious problem after gynaecologic oncology surgery. Preventive bundles of interventions to reduce SSI risk have been developed in various surgical subspecialties. This study evaluated the impact of a preventive bundle on SSI rates in gynaecologic oncology surgery.

New publication on the control of Hib disease burden in Europe

03-10-2017
Infanrix hexa’s major contribution to the control of Hib disease burden in Europe

Demo Article about Infanrix

22-05-2017
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Demo Article about Relvar

27-04-2017
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Demo Article about Triumeq

12-04-2017
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Demo Article about Benlysta

28-03-2017
Smoking large numbers of cigarettes causes COPD and that is not a secret. So why do so mych people smoke?

Demo Article about Nucala

18-03-2017
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Demo Article about Avamys

17-03-2017
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Demo Article about Rotarix

16-03-2017
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Demo Article about Infanrix

17-02-2017
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Demo Article about Tivicay

13-02-2017
News on allergy related treatments, atopia etc. Many interesting information on allergies.

Demo Article about Avamys

22-01-2017
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Prostatic urethral angle could predict response to α-blockers in patients with lower urinary tract symptoms

20-01-2017
Research shows that a lower prostatic urethral angle (<33.5°) in patients with LUTS could predict improved response to α-blockers for treatment of nocturia.

Updated guidelines for the management and treatment of patients with benign prostatic hyperplasia

20-01-2017
Updated guidelines for the treatment and management of patients with benign prostatic hyperplasia recommended by researchers from Toronto, Canada.

MRI imaging for characterisation of benign prostatic hyperplasia

20-01-2017
Researchers from Chicago suggest that superior contrast of MRI appears better than ultrasound for classification of types of benign prostatic hyperplasia.

Significance of resistive index of prostatic arteries in diagnosis of BPH

20-01-2017
A prospective study in Korea shows the clinical significance of the resistive index of prostatic blood flow for non-invasive diagnosis of BPH with LUTS

UroLift in the management of BPH

20-01-2017
A review of the UroLift system in the management of benign prostatic hyperplasia, considering the technique, advantages, limitations and concerns.

The relationship between metabolic syndrome, BPH and LUTS

20-01-2017
A new study published in Urology journal has identified that metabolic syndrome is significantly associated with predictors of BPH and the severity of LUTS

Androgen receptor expression in benign and malignant epithelium

20-01-2017
Staining intensity for the androgen receptor was more intense in cases of prostate cancer compared to benign prostatic hyperplasia

Economic analysis of PSA screening and treatment strategies

20-01-2017
Researchers from Seattle suggest strategies to extend PSA screening interval or higher PSA biopsy thresholds could preserve therapeutic benefit and cost.

Laser treatment for benign prostatic hyperplasia: a review

20-01-2017
Laser treatment for BPH rivals the gold-standard TURP with fewer complications. This review examines the most commonly used lasers in BPH surgery

HRQoL after prostatic surgery in patients with BPH in Singapore

20-01-2017
A study of Health-Related Quality of Life (HRQoL), sexual function and psychological well-being found that physical health of BPH patients after prostatic surgery was poor

The role of the endocrine system in BPH development

20-01-2017
A new review article published in Andrology summarises the influence of endocrine factors and inflammation in the pathogenesis of benign prostatic hyperplasisa

Demo Article about Triumeq

11-01-2017
Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Demo Article about Benlysta

11-12-2016
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Demo Article about Anoro

23-11-2016
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Demo Article about Rotarix

22-11-2016
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Demo Article about Relvar

08-11-2016
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Demo Article about Seretide

19-10-2016
Info on new inhalers part 2. Whatever random text. La La Land

Demo Article about Anoro

10-10-2016
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Demo Article about Nucala

04-10-2016
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua...

Demo Article about Relvar

03-10-2016
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

Demo Article about Seretide

01-10-2016
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

A review of the burden and control of allergic rhinitis

16-06-2016
A recent review discusses the impact of allergic rhinitis on patient perceived health and quality of life, and how control of symptoms can be measured.

Parasitic infection in chronic spontaneous urticaria

25-05-2016
A recent systematic review presents findings on the prevalence of parasitic infection in chronic spontaneous urticaria, and discusses likely pathomechanisms.

Challenges in seasonal allergic rhinitis

25-05-2016
Non-specific nasal challenge triggers neurogenic inflammation in patients with seasonal allergic rhinitis

Timing of infant vaccinations and allergic disease

25-05-2016
A recent study has linked delayed timing of infant diphtheria-tetanus-acellular pertussis vaccination with a decreased risk of eczema, but not food allergy.

Carbon monoxide increases risk of allergies in children

15-04-2016
Exposure to carbon monoxide increases risk of allergic disease in children.

Early-life vitamin D decreases risk of allergic rhinitis

15-04-2016
Maternal intake of vitamin D in food, but not in supplements, can reduce the risk of allergic rhinitis in children at school age.

Heterogeneity of allergic rhinitis and impact on asthma

15-04-2016
A patient survey investigated the heterogeneity of allergic rhinitis. Findings were related to the incidence and severity of asthma.

Homepage

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

Request a contact

Contact us now for any queries about our medicines, vaccines or our services.

Request a medical or scientific contact

Register for the latest news, updates, resources for different therapy areas and basic information about GSK medicines and vaccines.

Contact us now in GSK HCP portal

Contact us now for any queries about our medicines, vaccines or our services.

Rotarix

Rotavirus vaccine, live, oral suspension<br>Vaccines

Trelegy Ellipta

fluticasone furoate/umeclidinium/vilantero <br>Respiratory

Avamys

Fluticasone furoate<br>Respiratory

Avamys

Fluticasone furoate<br>Respiratory

Dovato

Dolutegravir/Lamivudine</br> HIV

Duodart

(dutasteride/tamsulosin HCI) Capsules<br> Urology

Avodart

Dutasteride<br>Urology

Nucala-MT

Mepolizumab<br> Respiratory

Nucala

Mepolizumab<br> Respiratory

HIV

We offer a wide range of HIV medicines to help more patients with HIV.

Seretide Adult

salmeterol xinafoate / fluticasone propionate<br>Respiratory

Dovato

Dolutegravir/Lamivudine</br> HIV

Dovato

Dolutegravir/Lamivudine</br> HIV

Augmentin

amoxicillin-clavulanate<br>Anti infectives

Bexsero

(Meningococcal Group B Vaccine rDNA, component, absorbed)<br>Vaccine

Benlysta

Belimumab<br> Immunology

Shingrix

(Zoster Vaccine Recombinant, Adjuvanted)

Rotarix

Rotavirus vaccine, live, oral suspension <br>Vaccines

Dovato

Dolutegravir/Lamivudine</br> HIV

ERS

Safety

This page contains information about safety

Parent support

This page contains parent support materials

Benlysta (belimumab) Efficacy in Patients with Renal Involvement – Information for Healthcare Professionals

Information on the Efficacy of Benlysta (belimumab) in Patients with Renal Involvement for Healthcare Professionals

Baseline Information

Benlysta (belimumab) Study Baseline Information for Healthcare Professionals

Benlysta (belimumab) Effects in Change in Organ Damage – Information for Healthcare Professionals

Information for Healthcare Professionals on how Benlysta (belimumab) Affects Change in Organ Damage

Benlysta (belimumab) Efficacy Information for Healthcare Professionals

Information on the Efficacy of Benlysta (belimumab) for Healthcare Professionals

Benlysta (belimumab) Product Dosing and Administration Information for Healthcare Professionals

Information for Healthcare Professionals on Dosing and Administration of Benlysta (belimumab)

Benlysta (belimumab) Patient Profiles for Healthcare Professionals

Profiles of Benlysta (belimumab) Patients intended for Healthcare Professionals

The STAT Study

The STAT Study

Real-World Evidence

Real-World Experience

The SALSA Study

The SALSA Study

The GEMINI Studies

The GEMINI Studies

The TANGO Study

The TANGO Study

Efficacy

Efficacy

Podcast

Podcasts of interest to HCPs who treat asthma

Anti infective

A quick look at Anti-Infectives.

Contact us now in GSK HCP portal

Contact us now for any queries about our medicines, vaccines or our services.

Resources

A dedicated page to patient and medical resources spanning GSK’s Therapy Areas and Brands.

Patient resources and samples

A dedicated page to patient and medical resources spanning GSK’s Therapy Areas and Brands

Medical Resources

A dedicated page to patient and medical resources spanning GSK’s Therapy Areas and Brands.

Anaesthesia

GSK offers a wide range of Anaesthesia medicines for different types of surgeries and patients.

Congress highlights from the ICAAC/ICC meeting 2015

Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and International Congress of Chemotherapy and Infection (ICC) 2015 meeting highlights.

Congress highlights from ESPID Annual Meeting 2015

Highlights from Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID 2015) – bacterial infections e-poster walk.

Highlights from the American Academy of Allergy, Asthma & Immunology Annual Meeting

Summary of the latest congress updates from different international congresses around the world in Allergy field.

GSK Allergy medicines

GSK offers a wide range of Allergy medicines for different type of patients

Journal Updates

Summary of the latest Journal updates from different international publishers around the world in Allergy field.

Corticosteroid prescriptions for chronic urticaria

A recent study revealed corticosteroid prescriptions for chronic spontaneous urticaria decreased following an evaluation by an allergy/immunology specialist.

Expression of microRNAs in asthma and allergic rhinitis

Patients with allergic rhinitis and asthma have uniquely expressed subsets of circulating microRNAs, according to a recent study in J Allergy Clin Immunol

Adverse drug reactions to second-generation antihistamines

A study of adverse drug reactions to second-generation antihistamines in children in the Netherlands found these may be more common than previously thought

Advice for pharmacists on allergic rhinitis

A recent article in Pharmacy Times highlighted the guidance pharmacists can offer to patients on the treatment and management of allergic rhinitis.

Seasonal allergies and climate change

A Focus article published in Environmental Health Perspectives summarises current knowledge on climate-induced changes in allergic symptoms

Sensitisation to common aeroallergens in Cameroon

A recent study in Cameroon has found a high prevalence of sensitisation to common aeroallergens amongst young adults.

Tyrosine kinase receptor limits type 2 immune response

A recent study in Science has identified a mechanism involving the receptor tyrosine kinase TYRO3, which limits the intensity of type 2 immune responses

Prevalence, comorbidities and treatment of allergic rhinitis

The prevalence, associated comorbidities, and treatment of allergic rhinitis have been investigated in a recent study published in Allergy.

Hydrolysed infant formula does not reduce risk of allergies

A recent study commissioned by the UK Food Standards Agency found no clear evidence that hydrolysed cow’s milk formula prevents allergic disease in high-risk infants.

Association of allergy, season of birth and DNA methylation

Patients with allergic rhinitis and asthma have uniquely expressed subsets of circulating microRNAs, according to a recent study in J Allergy Clin Immunol

News Updates

Summary of the latest News from different sources around the world in Allergy field.

Allergy

Therapy area information, latest congress, journals updates and news in Allergy field from different sources complemented by expert videos.

Heritage

HCPs can learn about GSK’s history and legacy in the vaccines business.

Frequently Asked Questions

HCPs can access a range of frequently asked questions regarding GSK vaccines and vaccination in general.

Our Portfolio

Healthcare professionals can see the range of vaccines in GSK’s portfolio.

How To Order

Find out how HCPs can order GSK vaccines online from vaccines.co.uk.

Highlights of the 9th WSPID congress

The 9th WSPID congress was held from 18–21 November 2015 in Brazil, with a focus on the treatment and prevention of paediatric infectious diseases.

Focus on RTI, highlights from ESPID 2016

Highlights of research on respiratory tract infections presented at the 2016 European Society for Paediatric Infectious Diseases meeting in Brighton, UK.

Highlights from the 26th ECCMID annual meeting 2016

Research highlights from the 26th annual European Congress of Clinical Microbiology and Infectious Diseases in Amsterdam, April 2016.

Congress Updates

Summary of the latest congress updates from different international congresses around the world in Anti infective field.

Links

Healthcare professionals can access a range of informative and helpful links related to vaccines.

Vaccine Slides

HCPs can access and download a range of informative slides about vaccines and the vaccination process.

Patient Support

HCPs can access materials and downloads which will be useful to their patient and practice

Useful HCP Resources

HCPs can access useful resources and downloads relating to GSK vaccines, travel health and vaccination in general.

Webcasts and Videos

HCPs can learn from experts in the vaccines field by watching on demand webcasts and videos.

Vaccines Overview Page

GSK UK information about our vaccines portfolio, as well as resources and latest news.

Congress Updates

Summary of the latest congress updates from different international congresses around the world in Allergy field.

Expert views

Watch experts’ videos in the Allergy field from different regional and global professors.

AASLD

Highlights from the EAU Congress, Munich 2016: understanding personalised medical management for BPH patients at risk of progression and for the elderly.

Congress Updates

Summary of the latest congress updates from different international congresses around the world in Urology field.

News Updates

Summary of the latest News from different sources around the world in Urology field.

Journal Updates

Summary of the latest Journal updates from different international publishers around the world in Urology field.

Hepatitis

GSK offers a range of Hepatitis medicines for different types of surgeries and patients.

Congress Updates

Summary of the latest congress updates from different international congresses around the world in Dermatology field.

News Updates

Summary of the latest News from different sources around the world in Dermatology field.

Dermatology Portfolio

GSK offers a wide range of Dermatological medicines for different type of patients

Disease Information

Overview on the different dermatological diseases, management guidlines and different patient presentations.

Expert views

Watch experts’ videos in the Dermatology field from different regional and global professors.

Journal Updates

Summary of the latest Journal updates from different international publishers around the world in Dermatology field.

Dermatology

Therapy area information, latest congress, journals updates and news in Dermatology field from different sources complemented by expert videos.

LUTS link to metabolic disorders

Summary of proceedings from ICI-RS 2014 highlighting potential links between lower urinary tract symptoms and metabolic disorders.

Innovations in BPH management

A review of recent technological innovations with potential clinical impact on the treatment of benign prostatic hyperplasia.

News Updates

Summary of the latest News from different sources around the world in Urology field.

European Association of Urology Congress 2016 highlights

Highlights from the EAU Congress, Munich 2016: understanding personalised medical management for BPH patients at risk of progression and for the elderly.

Congress Updates

Summary of the latest congress updates from different international congresses around the world in Urology field.

Disease Information

Overview on the BPH diagnosis and management.

Expert views

Watch experts’ videos in the Urology field from different regional and global professors.

Prostatic inflammation in REDUCE study participants

A recent analysis has investigated the effect of baseline inflammation on BPH-related parameters in placebo-treated participants of the 4-year REDUCE study

Sleep quality in people with LUTS and nocturia

A cross-sectional study in China has investigated the effect of nocturia on sleep quality and daytime functioning, specifically in people with LUTS

Urology

Therapy area information, latest congress, journals updates and news in Urology field from different sources complemented by expert videos

Registration Email Validation

Register now in Health.gsk for Health Care Professionals in Saudi Arabia to access GSK medicines and vaccine information, latest therapy area updates, online and on-demand webinars.

Registration Token

Register now in Health.gsk for Health Care Professionals in Saudi Arabia to access GSK medicines and vaccine information, latest therapy area updates, online and on-demand webinars.

Register now in GSK HCP portal

Register for the latest news, updates, resources for different therapy areas and basic information about GSK medicines and vaccines.

Reset Password Confirmation

Register now in Health.gsk for Health Care Professionals in Saudi Arabia to access GSK medicines and vaccine information, latest therapy area updates, online and on-demand webinars.

Login

Register now in Health.gsk for Health Care Professionals in Saudi Arabia to access GSK medicines and vaccine information, latest therapy area updates, online and on-demand webinars.

Login now in GSK HCP portal

Login for the latest news, updates, resources for different therapy areas and basic information about GSK medicines and vaccines.

Prostatic arterial embolization for BPH

A systematic review of clinical studies evaluates evidence for the use of prostatic arterial embolization in BPH with a discussion of outcomes and complications

Impact of storage and voiding LUTS on quality of life

Structural equation modelling showed that in BPH therapy, improvements in QoL were mainly due to improvement of storage lower urinary tract symptoms

Translational links in MetS, inflammation and LUTS

A systematic review concluded that metabolic syndrome and inflammation could be important contributors to LUTS in men

Prostate size as predictor of lower urinary tract symptoms

A post-hoc analysis of the REDUCE trial found that men with increased prostate size are at higher risk of incident lower urinary tract symptoms

Risk of major cardiac adverse events in males with LUTS

A systematic literature search and meta-analysis has found the risk of major cardiac adverse events is increased in males with LUTS

Monotherapies for BPH remain prevalent

Benign prostatic hyperplasia is commonly treated by monotherapy despite evidence from clinical trials indicating that combination therapy is more effective.

Metabolic syndrome associated with BPH in UK study

A cross-sectional UK epidemiological study has shown a significant association between benign prostatic hyperplasia and metabolic syndrome.

Journal Updates

Summary of the latest Journal updates from different international publishers around the world in Urology field.

Sexual Function

Information about our BPH portfolio and other resources designed to help healthcare professionals support their patients

Avodart

Information about our BPH portfolio and other resources designed to help healthcare professionals support their patients

Duodart

Information about our BPH portfolio and other resources designed to help healthcare professionals support their patients

Products

Information about our BPH portfolio and other resources designed to help healthcare professionals support their patients

Early Initiation

Information about our BPH portfolio and other resources designed to help healthcare professionals support their patients

Safety

Information about our BPH portfolio and other resources designed to help healthcare professionals support their patients

Efficacy

Information about our BPH portfolio and other resources designed to help healthcare professionals support their patients

BPH

May

Recommendations for SSI prevention in orthopaedic surgery

Surgical site infections (SSIs) in orthopaedic surgery remain a major problem that is challenging for surgeons and a potential disaster for patients. Although the evidence for preventative strategies continues to grow, many important issues remain unresolved. This review provides a synthesis of recently published guidelines and other relevant evidence.

Terms of Use

GSK UK healthcare professional website terms of use

Cookie Policy

Cookie information for users

Privacy Policy

GSK UK healthcare professional website privacy policy

Lamictal

Lamotrigine<br>Neuroscience

Twinrix

Inactivated hepatitis A and rDNA hepatitis B vaccine (adsorbed)<br>Vaccines

Boostrix

Combined diphtheria, tetanus, acellular pertussis vaccine<br>Vaccines

Anoro Ellipta

Umeclidinium/vilanterol<br> Respiratory

Relvar

Fluticasone furoate/vilanterol<br>Respiratory

Benlysta

Belimumab<br>Immunology

Zinnat

Cefuroxime<br>Anti infective

Infanrix Hexa

Diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type b (Hib) conjugate vaccine (adsorbed)<br>Vaccines

Duodart

0.5 mg dutasteride,0.4 mg tamsulosin hydrochlorid<br>Urology

Triumeq

Dolutegravir-abacavir-lamivudine<br>HIV

Seretide

Salmeterol/fluticasone propionate<br>Respiratory

Synflorix

Pneumococcal polysaccharide conjugate vaccine (adsorbed)<br>Vaccines

Keppra

Levetiracitam<br>Neuroscience

Trelegy

Fluticasone Furoate<br>Respiratory

Seroxat

Paroxetine hydrochloride<br>Neuroscience

Nucala

Mepolizumab<br>Respiratory

Flixotide

Fluticasone propionate<br>Respiratory

Rotarix

Rotavirus vaccine<br>Vaccines

Anoro Ellipta

Umeclidinium/vilanterol<br> Respiratory

Relvar Ellipta

Fluticasone furoate/vilanterol<br> Respiratory

Dovato-mt

Dolutegravir/Lamivudine<br>HIV

Synflorix

Pneumococcal polysaccharide conjugate vaccine (adsorbed)<br> Vaccines

May

Infanrix Hexa

Diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type b (Hib) conjugate vaccine (adsorbed)<br> Vaccines

Benlysta (belimumab)

Belimumab<br> Immunology

Boostrix

Combined diphtheria, tetanus, acellular pertussis vaccine<br>Vaccines

Menveo

Meningococcal Group A,C,W135 & Y Conjugate Vaccines </br>Vaccines

Duodart

0.5 mg dutasteride,0.4 mg tamsulosin hydrochlorid<br>Urology

keppra_new

Levetiracitam<br> Neuroscience

Augmentin

Amoxicillin trihydrate – Potassium clavulanate<br>Anti-infective

Flixotide

Fluticasone Propionate

Why vaccinate with Tdap during pregnancy?

Information for health care professionals about the Dosage and administration of Vaccines.

Maternal Immunization with Tdap vaccines

Information for health care professionals about the Dosage and administration of Vaccines.

Efficacy and Safety

Efficacy and Safety

What is the current safety and effectiveness information?

Information for health care professionals about the Dosage and administration of Vaccines.

Optimal timing to vaccinate

Information for health care professionals about the Dosage and administration of Vaccines.

Considerations to evaluate Maternal Immunization

Information for health care professionals about the Dosage and administration of Vaccines.

Maternal immunization offers passive immunity to the newborn via transplacental transfer of maternal antibodies

Information for health care professionals about the Dosage and administration of Vaccines.

How does Maternal Immunization Work?

Information for health care professionals about the Dosage and administration of Vaccines.

Newborns are at higher risk

Information for health care professionals about the Dosage and administration of Vaccines.

Maternal Immunization

Information for health care professionals about the Dosage and administration of Vaccines.

Recommendations

Information for health care professionals about the Dosage and administration of Vaccines.

Public health burden

Information for health care professionals about the Dosage and administration of Vaccines.

Why vaccinate with Tdap during pregnancy?

Information for health care professionals about the Dosage and administration of Vaccines.

Maternal Immunization with Tdap vaccines

Information for health care professionals about the Dosage and administration of Vaccines.

Invasive Meningococcal Disease (IMD) | BEXSERO

Learn more about invasive meningococcal disease (IMD) and how this potentially life threatening disease can be prevented through vacination.

Invasive Meningococcal Disease (IMD) | BEXSERO

Learn more about invasive meningococcal disease (IMD) and how this potentially life threatening disease can be prevented through vacination.

Boostrix

Combined diphtheria, tetanus, acellular pertussis vaccine<br>Vaccines

Bexsero

(Meningococcal Group B Vaccine rDNA, component, absorbed)<br>Vaccine

Efficacy COPD

Information for healthcare professionals about the clinical efficacy data for Seretide in patients with COPD

keppra_new

Levetiracitam<br> Neuroscience

Real World Data | BEXSERO (Meningococcal Group B Vaccine)

BEXSERO has demonstrated an impact in reducing cases of meingococcal disease. See real world data and evidence supporting BEXSERO's efficacy with patients.

Dosing and Administration

Dosing and Administration

Patient resources and samples

A dedicated page to patient and medical resources spanning GSK’s Therapy Areas and Brands

Safety

Relvar Ellipta is a once daily inhaled asthma therapy for patients with asthma, delivered through the easy-to-use Ellipta device

appropriate-patients

Appropriate patient

Dosage

Anoro Ellipta Dosage Guide, Anoro Inhaler (umeclidinium/vilanterol 62.5/25 micrograms)should be taken as one inhalation once daily by orally inhaled route

Efficacy

Relvar helped significantly more patients show improvement in ACT scores [1] and was superior to ICS/LABAs in helping more patients improve asthma control in everyday clinical practice

How Nucala works

How Nucala works

Therapeutic index

Therapeutic index

Augmentin Efficacy

Augmentin Efficacy antibiotic (Amoxicillin-Clavulanate) for genito urinary tract infections, Upper respiratory tract infections & Lower respiratory tract.

GSKpro | phase IV trial safety and immunogenicity data

New data from a phase IV clinical trial on the safety and immunogenicity of BOOSTRIX use during the 3rd trimester of pregnancy

Is Maternal Immunization safe?

Information for health care professionals about the Dosage and administration of Vaccines.

Is Maternal Immunization effective?

Information for health care professionals about the Dosage and administration of Vaccines.

Your role in prevention

Information for health care professionals about the Dosage and administration of Vaccines.

Communication is key

Information for health care professionals about the Dosage and administration of Vaccines.

How to implement Maternal Immunization

Information for health care professionals about the Dosage and administration of Vaccines.

new

Infanrix Hexa

Diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type b (Hib) conjugate vaccine (adsorbed)<br> Vaccines

Resources and Tools

Relvar Ellipta is a once daily inhaled asthma therapy for patients with asthma, delivered through the easy-to-use Ellipta device

Video Hub

COPD highlight videos.

Invasive Meningococcal Disease (IMD) | BEXSERO

Learn more about invasive meningococcal disease (IMD) and how this potentially life threatening disease can be prevented through vacination.

Efficacy

Anoro Efficacy Data in patients with Asthma and chronic obstructive pulmonary disease, To Compare Anoro (umeclidinium/vilanterol) lung function VS SPIRIVA

Invasive Meningococcal Disease (IMD) | BEXSERO

Learn more about invasive meningococcal disease (IMD) and how this potentially life threatening disease can be prevented through vacination.

Efficacy and Safety

Efficacy and Safety

Lamictal

Lamotrigine<br>Neuroscience

Twinrix

Inactivated hepatitis A and rDNA hepatitis B vaccine (adsorbed)<br> Vaccines

Avamys

Fluticasone furoate<br> Respiratory

Zinnat

Cefuroxime<br> Anti infective

Duodart

Dutasteride-tamsulosin HCl<br> Urology

Triumeq

Dolutegravir-abacavir-lamivudine<br> HIV

Seroxat

Paroxetine hydrochloride<br> Neuroscience

Flixotide Evohaler

Fluticasone propionate<br>Respiratory

Rotarix

Rotavirus vaccine, live, oral suspension<br> Vaccines

Patient Stories | BEXSERO (Meningococcal Group B Vaccine)

Read the true stories of patients and their family who have had experienced meningococcal disease firsthand.

Real World Data | BEXSERO (Meningococcal Group B Vaccine)

BEXSERO has demonstrated an impact in reducing cases of meingococcal disease. See real world data and evidence supporting BEXSERO's efficacy with patients.

Invasive Meningococcal Disease (IMD) | BEXSERO

Learn more about invasive meningococcal disease (IMD) and how this potentially life threatening disease can be prevented through vacination.

Benlysta (belimumab) Study Design for Healthcare Professionals

Information on Benlysta (belimumab) Study Design for Healthcare Professionals

Keppra_mt

levetiracetam

Therapy areas

Health.gsk for Health Care Professionals in Gulf to access GSK medicines and vaccine information, latest therapy area updates, online and on-demand webinars.

Bexsero

(Meningococcal Group B Vaccine rDNA, component, absorbed)<br>Vaccines

Heritage in BPH

Heritage in BPH page for BPH

boostrix_mt

Tetanus Toxoid, Reduced Diptheria Toxoid and Acellular Pertussis Vaccine, Adsorbed <br> Vaccine

Home

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) product information and resources to support HCPs in their daily practice.

Shingrix

(Zoster Vaccine Recombinant, Adjuvanted)

MOA

MOA

Efficacy

Efficacy of Benlysta

Safety

Safety of Benlysta Singapore

Home

Belimumab<br> Immunology

The STAT Study

The STAT Study

Efficacy

Efficacy

The TANGO Study

The TANGO Study

The GEMINI Studies

The GEMINI Studies

The SALSA Study

The SALSA Study

Real-World Evidence

Real-World Experience

Predict with MMR/MSI

Understand why dMMR/MSI-H testing can identify tumours that may respond to immunotheray

Test for dMMR/MSI-H early

Learn more about MMR/MSI testing to determine eligibility for treatment with immunotherapy in patient with endometrial cancer

Endometrial Cancer

Learn why biomarker driven therapies may redefine the future of treatment for patients with endometrial cancer

Long-term adherence

Long-term adherence page for BPH

Home

Homepage

Havrix

hepatitis A vaccine, inactivated<br>Vaccines

PHN and Sustained Efficacy

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) nearly eliminates the risk of developing PHN by preventing shingles

Scientific Rationale

Recommend the shingles vaccine specifically formulated to address age-related decline in immunity

Resources

Resources for HCPs and patients about SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted)

Efficacy Against Shingles

SHINGRIX delivered >90% efficacy against shingles in all age segments ≥50 years old

Safety

The safety of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) was extensively studied in 2 large phase 3 clinical trials

Patient Profiles

Is SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) right for your patients? Nearly everyone ≥50 years old needs shingles protection

Recommendation

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) is recommended by the CDC for the prevention of shingles (herpes zoster) and related complications for immunocompetent adults aged ≥50 years.

Home

amoxicillin-clavulanate<br>Anti infectives

Unmet Need

Patients ≥50 years old are at risk for shingles, no matter how healthy they may feel

SHINGRIX in your Practice

Read about SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) dosing and administration details, information to share with patients, and guidance for series completion

Study design

Explore ZEJULA (niraparib), including Phase 3 trial results and long-term efficacy and safety data

ZEJULA Overview

Explore ZEJULA (niraparib), including Phase 3 trial results and long-term efficacy and safety data

Home

Learn more about ZEJULA (niraparib), a PARP inhibitor for the maintenance treatment of advanced ovarian cancer

Resources overview

Access ZEJULA (niraparib) resources and support for clinics, healthcare professionals and patients

Resources

Access ZEJULA (niraparib) resources and support for clinics, healthcare professionals and patients

Tablet formulation

Access ZEJULA (niraparib) resources and support for clinics, healthcare professionals and patients

Expert perspectives

Access ZEJULA (niraparib) resources and support for clinics, healthcare professionals and patients

Patient support kit

Access ZEJULA (niraparib) resources and support for clinics, healthcare professionals and patients

Patient Experience

Discover the patient experience, and learn more about monitoring and management recommendations with ZEJULA (niraparib)

No results. Why not try:

  • Checking the spelling of the search term
  • Trying a different search term
  • Resetting or revising the filter settings (if you used filters to do this search)

Show more